Astellas Pharma Inc
Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceutical products worldwide. It offers XTANDI, an androgen receptor signaling inhibitor for the treatment of prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of overactive bladder (OAB); and Prograf and Advagraf/Graceptor/ASTAGRAF, which are immunosuppressants used to suppress organ transplant rejection. The company also provides Vesicare for OAB treatment; Eligard for prostate cancer treatment; Harnal/Omnic for benign prostatic hyperplasia treatment; and Funguard/MYCAMINE, an antifungal agent. The company has a clinical collaboration agreement with Merck & Co., Inc.; and CytomX Therapeutics, Inc. to develop Probody T-cell engaging bispecific therapies for treatment of cancer. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. Show More...
-
Website http://www.astellas.com
-
Sector Healthcare
-
Industry Drug Manufacturers-General
-
Last Quote 8.22 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 TTM Earnings Per Share JPY 52.32 29.26 8.46 32.16 40.39 61.4 89.62 103.55 81.02 114.94 117.3 Dividends JPY 25.0 25.0 25.0 26.0 24.16 30.0 32.0 34.0 36.0 38.0 39.0 Payout Ratio % * 85.4 66.4 93.3 73.2 53.4 37.5 33.7 39.3 33.7 33.3 Shares Mil 2.337 2.312 9.237 2.874 2.25 2.212 2.161 2.112 2.033 1.934 1.888 Book Value Per Share * EUR 3.76 3.88 3.87 3.67 4.82 4.89 5.32 5.26 5.51 6.0 Free Cash Flow Per Share * EUR 0.18 0.36 0.2 0.42 0.37 0.34 1.01 0.83 1.05 Return on Assets % 9.01 5.01 5.72 5.82 5.87 7.88 10.78 12.08 8.95 11.84 11.27 Financial Leverage (Average) 1.29 1.31 1.38 1.36 1.3 1.36 1.43 1.43 1.47 1.51 1.51 Return on Equity % 11.74 6.52 7.67 7.97 7.8 10.51 15.03 17.28 12.97 17.59 16.92 Return on Invested Capital % 11.56 6.45 7.61 7.94 7.47 10.28 14.3 16.0 12.68 17.24 16.73 Interest Coverage 461.05 74.57 62.63 161.89 143.6 123.4 192.22 102.67 Current Ratio 3.57 2.73 2.49 2.64 2.68 2.29 2.17 2.19 2.01 1.72 1.79 Quick Ratio 2.76 1.83 1.79 1.91 2.23 1.88 1.7 1.66 1.58 1.32 1.39 Debt/Equity